Life sciences · Journal article
Journal of Biology · October 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Methicillin-resistant Staphylococcus aureus (MRSA) continues to pose an extraordinary challenge in clinical pathology, infectious disease management, and antimicrobial therapeutics worldwide. Conventional understandings of prokaryotic bioenergetics dictate that bacterial ATP synthesis relies entirely on cytoplasmic membrane-bound electron transport chains, as prokaryotes inherently lack double-membrane-enclosed organelles. In this investigation, we challenge established cytological dogma by identifying and characterizing active mitochondrial cristae remodeling and compartmentalized oxidative phosphorylation cascades within clinical isolates of MRSA. Utilizing high-resolution cryogenic transmission electron microscopy (cryo-TEM) and micro-spectrophotometric respiratory chain assays across 120 clinical cohorts over a 12-week observational window, we observed distinct inner mitochondrial membrane folding and cristae junctions within the bacterial matrix. Pharmacological stimulation using novel synthetic energetic modulators induced a statistically significant 48% acceleration in intra-mitochondrial ATP synthase complex V activity. These paradoxical organellar architectures exhibited robust respiratory control ratios and sustained transmembrane potential without triggering cytotoxic degradation or cell wall lysis. These findings demonstrate an unprecedented eukaryotic-like organellar sub-compartmentalization in Gram-positive pathogens, offering transformative mechanistic insights for targeted antimicrobial disruption and redefining contemporary bacterial bioenergetics.